Condition
Vasodilatory Shock
Vasodilatory shock is a life-threatening state in which blood vessels widen so much that blood pressure falls and organs receive too little blood. The evidence is strong for vasopressin: in a randomized trial, average blood pressure was higher at 24 hours when it was added to norepinephrine than with norepinephrine alone. That finding concerns blood pressure support in critically ill people who were already receiving standard care.
Sources: PMID 12732600; PMID 12534330
- Updated
- How we grade
- 12 studies cited
- Supplements studied
- 0
- Medicines and peptides
- 1
- Graded outcomes
- 4
Prescription medicines and peptides studied, for context
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Mortality (Less Severe Sepsis) VASST trial: 28-day mortality 26.5% vs 35.7% (p=0.05) in less severe septic shock. No benefit in more severe shock. | Improves (the measure goes down) | Moderate effect | 12 studies | |||
Studies that measured mortality (less severe sepsis) | ||||||
| Norepinephrine Sparing Significantly reduces norepinephrine dose requirements at 24 and 48 hours. Allows weaning of catecholamines. | Improves (the measure goes down) | Large effect | 11 studies | |||
Studies that measured norepinephrine sparing | ||||||
| Blood Pressure Support FDA-approved for maintaining blood pressure in vasodilatory shock. MAP significantly higher at 24h with AVP+NE vs NE alone. | Improves (the measure goes up) | Large effect | 10 studies | |||
Studies that measured blood pressure support
| ||||||
| Hemodynamic Stabilization Heart rate lower at 24-48h with AVP. Effective even in catecholamine-resistant vasodilatory shock. | Improves (the measure goes up) | Large effect | 10 studies | |||
Studies that measured hemodynamic stabilization
| ||||||
Key findings
- Mortality (Less Severe Sepsis)Improves (the measure goes down)
- Norepinephrine SparingImproves (the measure goes down)
- Blood Pressure SupportImproves (the measure goes up)
Studies cited
12 studies from PubMed
- Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study
- Vasopressin and its analogues in shock states: a review
- The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience
- Vasopressin versus norepinephrine infusion in patients with septic shock
- Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury
- Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.
- Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
- Vasopressin: a new target for the treatment of heart failure
- Management of vasodilatory shock: defining the role of arginine vasopressin
- Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study
- A clinical review of the adaptive role of vasopressin in migraine.
- Central cardiovascular regulation and the role of vasopressin: a review.